Category Health Tech

Varian Launches IntelliBlate in Europe, Enhancing Image-Guided Cancer Treatment with Integrated Microwave Ablation Technology

Varian Launches IntelliBlate in Europe, Enhancing Image-Guided Cancer Treatment with Integrated Microwave Ablation Technology

Varian, a Siemens Healthineers company, today announced the European launch of IntelliBlate, its next generation microwave ablation solution, for the treatment of soft tissue tumors. Now CE-marked, IntelliBlate represents a…

Read MoreVarian Launches IntelliBlate in Europe, Enhancing Image-Guided Cancer Treatment with Integrated Microwave Ablation Technology
HistoSonics Secures Expanded Insurance Coverage for Liver Tumor Therapy, Reaching 7 Million Highmark Blue Cross Blue Shield Members

HistoSonics Secures Expanded Insurance Coverage for Liver Tumor Therapy, Reaching 7 Million Highmark Blue Cross Blue Shield Members

HistoSonics , maker of the Edison® Tissue Ablation System , today announced that Highmark Blue Cross Blue Shield has issued four new positive medical policy decisions for the use of Tissue Ablation…

Read MoreHistoSonics Secures Expanded Insurance Coverage for Liver Tumor Therapy, Reaching 7 Million Highmark Blue Cross Blue Shield Members
Petspan Unveils First Telemedicine Protocol with Rapamycin for Treating Feline Hypertrophic Cardiomyopathy

Petspan Unveils First Telemedicine Protocol with Rapamycin for Treating Feline Hypertrophic Cardiomyopathy

Petspan, the veterinary telemedicine division of longevity health company Healthspan, today announced the launch of the industry’s first remote-care protocol delivering rapamycin therapy to cats diagnosed with hypertrophic cardiomyopathy (HCM). Our HCM…

Read MorePetspan Unveils First Telemedicine Protocol with Rapamycin for Treating Feline Hypertrophic Cardiomyopathy
CorFlow Therapeutics Receives FDA Approval for MOCA-II Pivotal Trial of Innovative Heart Attack Treatment Technology

CorFlow Therapeutics Receives FDA Approval for MOCA-II Pivotal Trial of Innovative Heart Attack Treatment Technology

CorFlow Therapeutics AG  a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has approved the company’s technology for…

Read MoreCorFlow Therapeutics Receives FDA Approval for MOCA-II Pivotal Trial of Innovative Heart Attack Treatment Technology
Cancer Vaccine Market 2021–2031: Growth Driven by Precision Immunotherapy & Personalized Medicine

Cancer Vaccine Market 2021–2031: Growth Driven by Precision Immunotherapy & Personalized Medicine

The “Cancer Vaccine Market (2025 Edition): Analysis By Type (Preventative, Therapeutic), By Technology Type, By Region, By Country: Market Insights and Forecast (2021-2031)” report has been added to ResearchAndMarkets.com’s offering. The Global Cancer Vaccine…

Read MoreCancer Vaccine Market 2021–2031: Growth Driven by Precision Immunotherapy & Personalized Medicine